On October 25, 2018, CQSW, a leading blood purification technology provider in China, announced:
With years of technological accumulation and practice, the company has made breakthroughs in the spinning technology of hollow fiber membranes, and will use self-developed hollow fiber membranes for the production of dialyzers in the future.
CQSW is a national high-tech enterprise that integrates blood purification equipment, blood purification consumables, intelligent management system for hemodialysis centers, and chain hemodialysis centers, providing comprehensive blood purification solutions for kidney disease and critically ill patients worldwide.
CQSW is a leading enterprise in the field of blood purification technology in China and a drafting unit for national and industry standards in China.
Based on the core key technologies of original blood purification equipment, CQSW has independently developed continuous blood purification equipment (CRRT), blood dialysis machines, blood perfusion machines, as well as blood purification consumables such as dialyzers, dialysate filters, dialysis pipelines, perfusion machines, and dialysis powder/solution.
The product is widely used in clinical practice to treat various critical illnesses such as acute and chronic kidney failure, uremia, poisoning, and multiple organ failure. The company's series of products have been selected for the "Excellent Domestic Medical Equipment Product Selection" catalog.
In early July 2021, another blood purification medical device company in China announced that JXSX Medical Technology Corporation had achieved stable mass production of hollow fiber hemodialysis membranes.
Previously, only Membrana, a subsidiary of 3M Corporation in the United States, was able to provide this type of hollow fiber hemodialysis membrane on a large scale and stably worldwide.